Japan's Kirin Readies $780M Exit From Amgen Joint Venture
Japan's Kirin Holdings Co. Ltd. said Tuesday it will exit its pharmaceuticals research and development joint venture with California-based Amgen Inc. in a $780 million deal, noting that the U.S. venture...To view the full article, register now.
Already a subscriber? Click here to view full article